OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Investigational Hair Loss Therapeutic, OLX104C

[Balding curse]

“We are pleased to receive this notice of allowance from the USPTO which validates our novel approach to treating male pattern baldness,” said Dong Ki Lee, Ph.D., founder and chief executive officer of OliX Pharmaceuticals. “OliX is building a leading pipeline of RNAi therapeutics for dermatological conditions. We look forward to advancing development of OLX104C as quickly as possible given the millions of people who are affected by hair loss.”

OliX

www.olixpharma.com

 

[JaneyElizabeth]

“We are pleased to receive this notice of allowance from the USPTO which validates our novel approach to treating male pattern baldness,” said Dong Ki Lee, Ph.D., founder and chief executive officer of OliX Pharmaceuticals. “OliX is building a leading pipeline of RNAi therapeutics for dermatological conditions. We look forward to advancing development of OLX104C as quickly as possible given the millions of people who are affected by hair loss.”

OliX

www.olixpharma.com

It's always encouraging to see new corporate interest in balding palliatives.

 

[poopfeast420]

I'm excited for this treatment but receiving a patent has literally no connection to the potential efficacy of a treatment. All it means is that it (might be) novel

 

[kiwi666]

I'm excited for this treatment but receiving a patent has literally no connection to the potential efficacy of a treatment. All it means is that it (might be) novel

Exactly, what we have here is a novel idea. Well fuuuuuck them until I see a before and after treatment shot

 

[scientist_0005]

i wonder if this can be sourced from a chinese lab or if its just too complicated to make and too dangerous to even think about